EPRX
Price
$8.15Alerts
Change
+$0.34 (+4.35%)
Updated
Nov 13 closing price
Capitalization
455.25M
135 days until earnings call
Intraday BUY SELL Signals
LEXX
Price
$4.44Alerts
Change
+$0.26 (+6.22%)
Updated
Nov 13 closing price
Capitalization
9.48M
10 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

EPRX vs LEXX

EPRX vs LEXX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
EPRX vs. LEXX commentary
Nov 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EPRX is a Buy and LEXX is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for EPRX with price predictions
Nov 13, 2026

EPRX in upward trend: price rose above 50-day moving average on November 10, 2026

EPRX moved above its 50-day moving average on November 10, 2026 date and that indicates a change from a downward trend to an upward trend. In 37 of 44 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on EPRX as a result. In 64 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 75%.

The Moving Average Convergence Divergence (MACD) for EPRX just turned positive on November 09, 2026. Looking at past instances where EPRX's MACD turned positive, the stock continued to rise in 27 of 39 cases over the following month. The odds of a continued upward trend are 69%.

Following a +8.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where EPRX advanced for three days, in 101 of 125 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 10-day moving average for EPRX crossed bearishly below the 50-day moving average on October 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 83%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EPRX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.

EPRX broke above its upper Bollinger Band on November 11, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for EPRX entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 26 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.213) is normal, around the industry mean (3.498). P/E Ratio (-6.755) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.658) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).

The Tickeron Profit vs. Risk Rating rating for this company is 33 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. EPRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 59 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for LEXX with price predictions
Nov 13, 2026

LEXX in upward trend: price rose above 50-day moving average on November 09, 2026

LEXX moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend. In 42 of 47 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on LEXX as a result. In 69 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.

The 10-day moving average for LEXX crossed bullishly above the 50-day moving average on November 12, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 16 of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.

Following a +4.00% 3-day Advance, the price is estimated to grow further. Considering data from situations where LEXX advanced for three days, in 239 of 279 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

The Aroon Indicator entered an Uptrend today. In 111 of 145 cases where LEXX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 77%.

Bearish Trend Analysis

The 10-day RSI Indicator for LEXX moved out of overbought territory on November 11, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 28 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 12 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 50-day moving average for LEXX moved below the 200-day moving average on October 08, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LEXX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

LEXX broke above its upper Bollinger Band on November 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating steady price growth. LEXX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.001) is normal, around the industry mean (3.498). P/E Ratio (-0.882) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.658) among similar stocks. P/S Ratio (23.310) is also within normal values, averaging (440.869).

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LEXX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
LEXX: Fundamental Ratings
LEXX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EPRXLEXX
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
68%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
Bullish Trend 3 days ago
69%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
54%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
55%
Bullish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 6 days ago
86%
Declines
ODDS (%)
Bearish Trend 11 days ago
74%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
87%
Aroon
ODDS (%)
Bearish Trend 3 days ago
46%
Bullish Trend 3 days ago
77%
COMPARISON
Comparison
Nov 15, 2026
Stock price -- (EPRX: $8.15 vs. LEXX: $4.44)
Brand notoriety: EPRX and LEXX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EPRX: 103% vs. LEXX: 16%
Market capitalization -- EPRX: $455.25M vs. LEXX: $9.48M
EPRX [@Biotechnology] is valued at $455.25M. LEXX’s [@Biotechnology] market capitalization is $9.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EPRX’s FA Score shows that 2 FA rating(s) are green while LEXX’s FA Score has 0 green FA rating(s).

  • EPRX’s FA Score: 2 green, 3 red.
  • LEXX’s FA Score: 0 green, 5 red.
According to our system of comparison, EPRX is a better buy in the long-term than LEXX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EPRX’s TA Score shows that 4 TA indicator(s) are bullish while LEXX’s TA Score has 5 bullish TA indicator(s).

  • EPRX’s TA Score: 4 bullish, 5 bearish.
  • LEXX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, LEXX is a better buy in the short-term than EPRX.

Price Growth

EPRX (@Biotechnology) experienced а +18.29% price change this week, while LEXX (@Biotechnology) price change was -1.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.38%. For the same industry, the average monthly price growth was -5.88%, and the average quarterly price growth was -18.27%.

Reported Earning Dates

EPRX is expected to report earnings on Mar 30, 2027.

LEXX is expected to report earnings on Nov 25, 2026.

Industries' Descriptions

@Biotechnology (-3.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

EPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, EPRX has been loosely correlated with ASMB. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if EPRX jumps, then ASMB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EPRX
1D Price
Change %
EPRX100%
+4.35%
ASMB - EPRX
38%
Loosely correlated
+4.66%
TARS - EPRX
37%
Loosely correlated
+4.41%
NAMS - EPRX
36%
Loosely correlated
+0.85%
EDIT - EPRX
34%
Loosely correlated
+1.40%
VERA - EPRX
34%
Loosely correlated
-3.24%
More

LEXX and

Correlation & Price change

A.I.dvisor tells us that LEXX and ASMB have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LEXX and ASMB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LEXX
1D Price
Change %
LEXX100%
+6.22%
ASMB - LEXX
29%
Poorly correlated
+4.66%
MIST - LEXX
28%
Poorly correlated
-20.63%
EPRX - LEXX
27%
Poorly correlated
+4.35%
MDXG - LEXX
26%
Poorly correlated
-0.93%
NKTX - LEXX
26%
Poorly correlated
-5.93%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MLCO4.280.10
+2.39%
Melco Resorts & Entertainment Limited
HOWL0.98N/A
+0.03%
Werewolf Therapeutics
EPAM163.15-0.68
-0.42%
Epam Systems
BPYPO14.55-0.14
-0.95%
Brookfield Property Partners LP
TLS7.35-0.37
-4.79%
Telos Corp
Interesting Articles